Navigation Links
Global Patient Recruitment Company CSSi Launches Redesigned Website
Date:5/10/2017

GLEN BURNIE, Md., May 10, 2017 /PRNewswire/ -- CSSi, the global leader in patient recruitment, enrollment and retention solutions for the clinical research industry, is proud to announce the launch of its newly redesigned website, www.CSSiEnroll.com. The new website features both enriched content and a customized layout that provides a better overall user experience and enhances the company's already well-established position as the top global patient recruitment company in the industry.

"After many months of hard work, we are delighted to officially announce the relaunch of our new and improved company website," said Chris Trizna, President, CSSi. "We hope our redesigned website exceeds our current and prospective clients' expectations; we really worked hard to make sure it contains valuable patient recruitment information, solutions and services to assist them with meeting their enrollment goals. With the changes and upgrades, we expect maximized audience engagement and tremendous leads through our new convenient, user-friendly website."

The goal of CSSi's website redevelopment effort was focused on aesthetics, simplifying content and increasing the visibility of the company's brand. The new website is both visually appealing and user-friendly which provides visitors with streamlined menus, clear navigation and better access to useful information about the company's outstanding services and recent successes.

Newly revamped pages of www.CSSiEnroll.com include:

  • Capabilities – Navigate through a library of tools and service offerings, customizable to each study, that CSSi utilizes to ensure the most efficient and cost-effective method to reaching a client's enrollment goals.
  • Therapeutic Areas & Case Studies – Highlights CSSi's vast patient recruitment experience, with the completion of over 1,200 studies in the last three years within 17 therapeutic areas and 120 unique indications.
  • CSSi Creative Profile – Showcases the company's broad scope of work and various creatives that have been used to successfully recruit patients. Users can get an in-depth look into CSSi's creative development process, which involves a thorough analysis of the industry, health indication and a client's needs and challenges. CSSi strives to develop a unique, powerful study brand and the enrollment tools that each investigative site needs to effectively enroll study subjects.

The website relaunch comes on the heels of CSSi's 12-year anniversary. "I am so incredibly proud of my team and all that we have accomplished over the years and to be a part of an industry that brings new drugs and devices to market to help people with chronic illnesses all across the globe. Our quality of work has been top notch and crucial to our continued patient recruitment success. We look forward to many more years of growth for CSSi and the industry!" added Trizna.

About CSSi:
CSSi delivers global patient recruitment solutions to study sponsors, CROs, SMOs and investigative sites that ensure successful enrollment on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSSi is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. For more information on CSSi, please visit: www.CSSiEnroll.com, email: info@CSSiEnroll.com. or call: (866) 277-4888.

Follow Us!
Facebook.com/CSSiEnrollTwitter.com/EnrollPatientsLinkedIn.com/company/Clinical-Site-Services

Media Contact:
Courtney Megaughey
CSSi
(443) 308-5831
158899@email4pr.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-patient-recruitment-company-cssi-launches-redesigned-website-300454968.html


'/>"/>
SOURCE CSSi
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Research and Markets - Global Biosimilar Pipeline and Market Prospects 2017-2022: Focus on Basaglar, Inflectra, Benepali, Rituximab, Trastuzumab, Adalimumab and Bevacizumab
2. Global $20 Billion Drug Delivery Technologies Market 2016-2020 - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics - Research and Markets
3. Global $11.93 Billion Pharmacogenomics Market 2014-2017 & 2024 - Research and Markets
4. Digital Mobile X-Ray Devices Market: Handheld Devices Segment Estimated to Register a High CAGR of 8.6% During the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026
5. Surgical Drainage Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
6. Prostate Cancer Therapeutics Market ; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
7. Companion Animal Vaccines Market: Canine Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026
8. Global Arthroscopy Devices Market - Analysis, Technologies and Forecasts to 2021 - Growing Use of Robotic-assisted Techniques - Research and Markets
9. Research and Markets - Global Antiviral Drugs Market to Grow at a CAGR of 9.48%, 2017-2021 with Bristol-Myers Squibb, F. Hoffmann-La Roche, Gilead Sciences & GlaxoSmithKline Leading the Market
10. Global Pharmerging Market to Reach US$1.40 Billion by 2024: Increasing Government Expenditure on Healthcare to Boost Growth, Says TMR
11. Global Urology Surgical Instrument Market 2017-2022: Increasing Prevalence Of Chronic Kidney Diseases And Urinary Tract Infections - Research and Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):